Ex parte LAURENCIN et al. - Page 7




                   Appeal No. 1997-2634                                                                                                                             
                   Application 08/222,662                                                                                                                           
                   claimed porous polyphosphazene structure, replacing the structure with bone as the                                                               
                   polyphosphazene degrades.  Brief, section V.                                                                                                     
                            In our view, the mere fact that Elia’s porous, biodegradable polyphosphazene                                                            
                   matrix forms a temporary container, or pocket, for a “bone augmenting” substance, rather                                                         
                   than forming the bone augmenting substance itself, does not distinguish it from the claimed                                                      
                   matrix.  Both Elia’s container and the claimed polyphosphazene matrix are porous,                                                                
                   biodegradable structures implanted at a site “for repair or replacement of bone.”                                                                
                   Nevertheless, Elia does not disclose the particular polyphosphazene derivatives, or narrow                                                       
                   range of porosity, required by the claims.  Thus, the ultimate issue raised by the examiner’s                                                    
                   rejection is whether the prior art provides a reason or suggestion which would have                                                              
                   reasonably directed one skilled in the art to the claimed invention: a porous biodegradable                                                      
                   structure, made up of the same polyphosphazene derivatives disclosed by Laurencin, “with                                                         
                   pore dimensions of between 100 and 250 microns”.6                                                                                                
                            Returning to Elia’s disclosure, we note that there is no indication that the porous                                                     
                   containment system functions as a growth surface for osteoblasts.  Indeed, its purpose is                                                        
                   to hold hydroxyapatite or a similar “bone regeneration material” against existing bone, and                                                      
                   to control the passage of nutrients and other substances into and out of the bone                                                                


                            6As stated in Pro-Mold & Tool Co. v. Great Lakes Plastics, Inc., 75 F.3d 1568,                                                          
                   1573, 37 USPQ2d 1626, 1629 (Fed. Cir. 1996) (citation omitted), “It is well-established                                                          
                   that before a conclusion of obviousness may be made based on a combination of                                                                    
                   references, there must have been a reason, suggestion, or motivation to lead an inventor                                                         
                   to combine those references.”                                                                                                                    
                                                                                 7                                                                                  





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007